Veer Bhavnagri - 13 Feb 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
General Counsel
Signature
/s/Veer Bhavnagri
Issuer symbol
ALLO
Transactions as of
13 Feb 2023
Net transactions value
-$20,550
Form type
4
Filing time
14 Feb 2023, 16:10:36 UTC
Previous filing
18 Jan 2023
Next filing
16 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale $20,550 -3,000 -0.52% $6.85 577,677 13 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.